POMICELL’s state-of-the-art technology and methodologies bring Artificial Intelligence (AI) and Machine Learning based data analysis as driving force to R&D processes of Biotech and Pharma.
POMICELL's new platform for scientists
is expected to be launched in 2020
What makes POMICELL’s AI-powered machine learning system unique is it's methodologies and approach.
We tailor a fast, personal, and cost-effective computational solution to biotech companies’ specific research needs. Our ever-augmenting multilayered metadata space, together with our automatic tools, makes every relevant piece of life-science information readily available and usable for our partners.
POMICELL’s agile and adaptive technology doesn’t replace human researchers. Instead, it multiplies the human abilities, and mimics how researchers generate ideas and think. Automating the process, Pomicell draws clear, personally customized drug development road-maps navigating it's partners through the metadata space toward achieving their R&D goals.